The multifaceted interactions between Newcastle disease virus proteins and host proteins: a systematic review

References

• Amarasinghe GK, Ayllon MA, Bao Y, et al. Taxonomy of the order mononegavirales: update 2019. Arch Virol. 2019;164(7):1967–15. doi: 10.1007/s00705-019-04247-4
   PubMed Web of Science ®Google Scholar
• Alexander DJ. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech. 2000;19(2):443–62. doi: 10.20506/rst.19.2.1231
   PubMed Web of Science ®Google Scholar
• de Leeuw OS, Koch G, Hartog L, et al. Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin–neuraminidase protein. J Gen Virol. 2005;86(6):1759–1769. doi: 10.1099/vir.0.80822-0
   PubMedGoogle Scholar
• Habib M, Yaqub T, Nazir J, et al. Genomic and biological characterization of Newcastle disease viruses isolated from migratory mallards (Anas platyrhynchos). Arch Virol. 2018;163(8):2179–2188. doi: 10.1007/s00705-018-3840-8
   PubMed Web of Science ®Google Scholar
• Dimitrov KM, Abolnik C, Afonso CL, et al. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect Genet Evol. 2019;74:103917. doi: 10.1016/j.meegid.2019.103917
   PubMed Web of Science ®Google Scholar
• Samuel A, Nayak B, Paldurai A, et al. Phylogenetic and pathotypic characterization of Newcastle disease viruses circulating in west Africa and efficacy of a current vaccine. J Clin Microbiol. 2013;51(3):771–81. doi: 10.1128/JCM.02750-12
   PubMed Web of Science ®Google Scholar
• Dimitrov KM, Ramey AM, Qiu X, et al. Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infect Genet Evol. 2016;39:22–34. doi: 10.1016/j.meegid.2016.01.008
   PubMed Web of Science ®Google Scholar
• Morrison TG. Structure and function of a paramyxovirus fusion protein. Biochim Biophys Acta. 2003;1614(1):73–84. doi: 10.1016/S0005-2736(03)00164-0
   PubMed Web of Science ®Google Scholar
• Alexander DJ. Newcastle disease and other avian paramyxovirus. Rev Sci Tech. 2000;19(2):443–462. doi: 10.20506/rst.19.2.1231
   PubMed Web of Science ®Google Scholar
• Chen L, Song J, Liu H, et al. Phylodynamic analyses of class I Newcastle disease virus isolated in China. Transbound Emerg Dis. 2021;68(3):1294–1304. doi: 10.1111/tbed.13785
   PubMed Web of Science ®Google Scholar
• Jadhav A, Zhao L, Ledda A, et al. Patterns of RNA editing in Newcastle disease virus infections. Viruses. 2020;12(11):1249. doi: 10.3390/v12111249
   PubMed Web of Science ®Google Scholar
• Jin J, Zhao J, Ren Y, et al. Contribution of HN protein length diversity to Newcastle disease virus virulence, replication and biological activities. Sci Rep. 2016;6(1):36890. doi: 10.1038/srep36890
   PubMed Web of Science ®Google Scholar
• Porotto M, Salah Z, DeVito I, et al. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol. 2012;86(10):5730–41. doi: 10.1128/JVI.06793-11
   PubMed Web of Science ®Google Scholar
• Chi M, Xie W, Liu Y, et al. Mutations in the DI-DII linker of the NDV fusion protein conferred hemagglutinin-neuraminidase-independent cell fusion promotion. J Gen Virol. 2019;100(6):958–967. doi: 10.1099/jgv.0.001278
   PubMed Web of Science ®Google Scholar
• Ji Y, Liu T, Jia Y, et al. Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens. Virology. 2017;509:146–151. doi: 10.1016/j.virol.2017.06.021
   PubMed Web of Science ®Google Scholar
• Molouki A, Peeters B. Rescue of recombinant Newcastle disease virus: a short history of how it all started. Arch Virol. 2017;162(7):1845–1854. doi: 10.1007/s00705-017-3308-2
   PubMed Web of Science ®Google Scholar
• Fearns R, Plemper RK. Polymerases of paramyxoviruses and pneumoviruses. Virus Res. 2017;234:87–102. doi: 10.1016/j.virusres.2017.01.008
   PubMed Web of Science ®Google Scholar
• Kong L, You R, Zhang D, et al. Infectious bronchitis virus infection increases pathogenicity of H9N2 avian influenza virus by inducing severe inflammatory response. Front Vet Sci. 2021;8:824179. doi: 10.3389/fvets.2021.824179
   PubMed Web of Science ®Google Scholar
• Iorio RM, Field GM, Sauvron JM, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J Virol. 2001;75(4):1918–27. doi: 10.1128/JVI.75.4.1918-1927.2001
   PubMed Web of Science ®Google Scholar
• Knott GJ, Bond CS, Fox AH. The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. 2016;44(9):3989–4004. doi: 10.1093/nar/gkw271
   PubMed Web of Science ®Google Scholar
• Perreira JM, Chin CR, Feeley EM, et al. Ifitms restrict the replication of multiple pathogenic viruses. J Mol Biol. 2013;425(24):4937–55. doi: 10.1016/j.jmb.2013.09.024
   PubMed Web of Science ®Google Scholar
• Liu P, Tang N, Meng C, et al. SLC1A3 facilitates Newcastle disease virus replication by regulating glutamine catabolism. Virulence. 2022;13(1):1407–1422. doi: 10.1080/21505594.2022.2112821
   PubMed Web of Science ®Google Scholar
• Gong Y, Tang N, Liu P, et al. Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells. Autophagy. 2022;18(7):1503–1521. doi: 10.1080/15548627.2021.1990515
   PubMed Web of Science ®Google Scholar
• Kho CL, Tan WS, Tey BT, et al. Regions on nucleocapsid protein of Newcastle disease virus that interact with its phosphoprotein. Arch Virol. 2004;149(5):997–1005. doi: 10.1007/s00705-003-0273-8
   PubMed Web of Science ®Google Scholar
• Makkay AM, Krell PJ, Nagy E. Antibody detection-based differential ELISA for NDV-infected or vaccinated chickens versus NDV HN-subunit vaccinated chickens. Vet Microbiol. 1999;66(3):209–222. doi: 10.1016/S0378-1135(99)00016-4
   PubMed Web of Science ®Google Scholar
• Zhang G, Xue J, Li X. The influence of Newcastle disease virus major proteins on virulence. Vet Sci Res. 2021;3(02). doi: 10.30564/vsr.v3i2.4098
   Google Scholar
• El Najjar F, Schmitt AP, Dutch RE. Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses. 2014;6(8):3019–54. doi: 10.3390/v6083019
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Samal SK. Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J Gen Virol. 1998;79(Pt 10):2419–2424. doi: 10.1099/0022-1317-79-10-2419
   PubMedGoogle Scholar
• Pantua HD, Mcginnes LW, Peeples ME, et al. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol. 2006;80(22):11062–11073. doi: 10.1128/JVI.00726-06
   PubMed Web of Science ®Google Scholar
• Zhan Y, Yu S, Yang S, et al. Newcastle disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E. PLOS Pathog. 2020;16(6):e1008610. doi: 10.1371/journal.ppat.1008610
   PubMed Web of Science ®Google Scholar
• Penney J, Tsurudome K, Liao EH, et al. LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction. Nat Commun. 2016;7(1):12188. doi: 10.1038/ncomms12188
   PubMedGoogle Scholar
• Li X, Sun L, Zhao J, et al. Mutations in the methyltransferase motifs of L protein attenuate Newcastle disease virus by regulating viral translation and cell-to-cell spread. Microbiol Spectr. 2021;9(2):e0131221. doi: 10.1128/Spectrum.01312-21
   PubMed Web of Science ®Google Scholar
• Shizuo A, Uematsu S, Takeuchi O, et al. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. doi: 10.1016/j.cell.2006.02.015
   PubMed Web of Science ®Google Scholar
• Gack MU, Albrecht RA, Urano T, et al. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5(5):439–49. doi: 10.1016/j.chom.2009.04.006
   PubMed Web of Science ®Google Scholar
• Xu Q, Liang J, Jin J, et al. Newcastle disease virus nucleocapsid protein mediates the degradation of 14-3-3ε to antagonize the interferon response and promote viral replication. Vet Microbiol. 2023;284:109851. doi: 10.1016/j.vetmic.2023.109851
   PubMed Web of Science ®Google Scholar
• Paldurai A Determination of Genetic Factors Involved in the Virulence of Newcastle Disease Virus. Doctoral dissertation. 2012.
   Google Scholar
• Kumar R, Tiwari AK, Chaturvedi U, et al. Cloning and expression analysis of multiple proteins encoding P gene of Newcastle disease virus. Indian J Exp Biol. 2013;51(2):116–23.
   PubMed Web of Science ®Google Scholar
• Cong J, Feng X, Kang H, et al. Structure of the Newcastle disease virus L protein in complex with tetrameric phosphoprotein. Nat Commun. 2023;14(1):1324. doi: 10.1038/s41467-023-37012-y
   PubMed Web of Science ®Google Scholar
• Gerard FC, Ribeiro Ede A Jr., Leyrat C, et al. Modular organization of rabies virus phosphoprotein. J Mol Biol. 2009;388(5):978–996. doi: 10.1016/j.jmb.2009.03.061
   PubMed Web of Science ®Google Scholar
• Romer-Oberdorfer A, Mundt E, Mebatsion T, et al. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol. 1999;80(Pt 11):2987–2995. doi: 10.1099/0022-1317-80-11-2987
   PubMedGoogle Scholar
• Yu X, Cheng J, He Z, et al. The glutamic residue at position 402 in the C-terminus of Newcastle disease virus nucleoprotein is critical for the virus. Sci Rep. 2017;7(1):17471. doi: 10.1038/s41598-017-17803-2
   PubMedGoogle Scholar
• Errington W, Emmerson PT. Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. J Gen Virol. 1997;78(Pt 9):2335–2339. doi: 10.1099/0022-1317-78-9-2335
   PubMedGoogle Scholar
• Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol & Cell Proteomics. 2014;13(2):397–406. doi: 10.1074/mcp.M113.035600
   PubMed Web of Science ®Google Scholar
• Roche MI, Ramadas RA, Medoff BD. The role of CARMA1 in T cells. Crit Rev Immunol. 2013;33(3):219–43. doi: 10.1615/CritRevImmunol.2013007056
   PubMed Web of Science ®Google Scholar
• Juilland M, Thome M. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. Curr Opin Hematol. 2016;23(4):402–9. doi: 10.1097/MOH.0000000000000257
   PubMed Web of Science ®Google Scholar
• Wang W, Chang X, Yao W, et al. Host CARD11 inhibits Newcastle disease virus replication by suppressing viral polymerase activity in neurons. J Virol. 2019;93(24):e01499–19. doi: 10.1128/JVI.01499-19
   PubMed Web of Science ®Google Scholar
• Wang W, Wei Q, Hao Q, et al. Cellular CARD11 inhibits the fusogenic activity of Newcastle disease virus via CBM signalosome-mediated furin reduction in chicken fibroblasts. Front Microbiol. 2021;12:607451. doi: 10.3389/fmicb.2021.607451
   PubMed Web of Science ®Google Scholar
• Cheng X, Wang W, Xu Q, et al. Genetic modification of oncolytic Newcastle disease virus for cancer therapy. J Virol. 2016;90(11):5343–5352. doi: 10.1128/JVI.00136-16
   PubMed Web of Science ®Google Scholar
• Park MS, Shaw ML, Munoz-Jordan J, et al. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol. 2003;77(2):1501–1511. doi: 10.1128/JVI.77.2.1501-1511.2003
   PubMed Web of Science ®Google Scholar
• Ganar K, Das M, Sinha S, et al. Newcastle disease virus: current status and our understanding. Virus Res. 2014;184:71–81. doi: 10.1016/j.virusres.2014.02.016
   PubMed Web of Science ®Google Scholar
• Hagmaier K, Stock N, Precious B, et al. Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs. J Gen Virol. 2007;88(Pt 3):956–966. doi: 10.1099/vir.0.82579-0
   PubMedGoogle Scholar
• Qiu X, Fu Q, Meng C, et al. Kinetic analysis of RNA editing of Newcastle disease virus P gene in the early period of infection. Acta Virol. 2016;60(1):71–77. doi: 10.4149/av_2016_01_71
   PubMed Web of Science ®Google Scholar
• Samson AC, Levesley I, Russell PH. The 36K polypeptide synthesized in Newcastle disease virus-infected cells possesses properties predicted for the hypothesized ‘V’ protein. J Gen Virol. 1991;72(Pt 7):1709–13. doi: 10.1099/0022-1317-72-7-1709
   PubMedGoogle Scholar
• Nishio M, Tsurudome M, Garcin D, et al. Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping. J Virol. 2011;85(2):725–32. doi: 10.1128/JVI.01226-10
   PubMed Web of Science ®Google Scholar
• Jia D, Rahbar R, Chan RW, et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One. 2010;5(11):e13927. doi: 10.1371/journal.pone.0013927
   PubMed Web of Science ®Google Scholar
• Pauli EK, Schmolke M, Wolff T, et al. Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression. PLOS Pathog. 2008;4(11):e1000196. doi: 10.1371/journal.ppat.1000196
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Ren J, et al. Newcastle disease virus nonstructural v protein upregulates SOCS3 expression to facilitate viral replication depending on the MEK/ERK Pathway. Front Cell Infect Microbiol. 2019;9:317. doi: 10.3389/fcimb.2019.00317
   PubMed Web of Science ®Google Scholar
• Bhoj VG, Sun Q, Bhoj EJ, et al. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. P Natl Acad Sci USA. 2008;105(37):14046–51. doi: 10.1073/pnas.0804717105
   PubMed Web of Science ®Google Scholar
• Sun Y, Zheng H, Yu S, et al. Newcastle disease virus v protein degrades mitochondrial antiviral signaling protein to inhibit host type I interferon production via E3 ubiquitin ligase RNF5. J Virol. 2019;93(18):e00322–19. doi: 10.1128/JVI.00322-19
   PubMed Web of Science ®Google Scholar
• Morita N, Tanaka Y, Odkhuu E, et al. Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages. Microbes Infect. 2020;22(8):322–330. doi: 10.1016/j.micinf.2020.01.005
   PubMed Web of Science ®Google Scholar
• Uchida S, Horie R, Sato H, et al. Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein1. Sci Rep. 2018;8(1):7682. doi: 10.1038/s41598-018-25815-9
   PubMedGoogle Scholar
• Civas A, Island ML, Génin P, et al. Regulation of virus-induced interferon-A genes. Biochimie. 2002;84(7):643–54. doi: 10.1016/S0300-9084(02)01431-1
   PubMed Web of Science ®Google Scholar
• Qiu X, Fu Q, Meng C, et al. Newcastle disease virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling. PLoS One. 2016;11(2):e0148560. doi: 10.1371/journal.pone.0148560
   PubMed Web of Science ®Google Scholar
• Motz C, Schuhmann KM, Kirchhofer A, et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science. 2013;339(6120):690–3. doi: 10.1126/science.1230949
   PubMed Web of Science ®Google Scholar
• Nan FL, Zhang H, Nan WL, et al. Lentogenic NDV V protein inhibits IFN responses and represses cell apoptosis. Vet Microbiol. 2021;261:109181. doi: 10.1016/j.vetmic.2021.109181
   PubMed Web of Science ®Google Scholar
• Xu W, Wang S, Chen Q, et al. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. Cell Death Dis. 2014;5(2):e1055. doi: 10.1038/cddis.2014.27
   PubMedGoogle Scholar
• Ni P, Xu W, Zhang Y, et al. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines. Curr Cancer Drug Tar. 2015;14(9):850–9. doi: 10.2174/1568009614666141028094612
   PubMed Web of Science ®Google Scholar
• Wang C, Chu Z, Liu W, et al. Newcastle disease virus V protein inhibits apoptosis in DF-1 cells by downregulating TXNL1. Vet Res. 2018;49(1):102. doi: 10.1186/s13567-018-0599-6
   PubMedGoogle Scholar
• Bish R, Vogel C. RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma. Mol Cells. 2014;37(5):357–64. doi: 10.14348/molcells.2014.0008
   PubMed Web of Science ®Google Scholar
• Yang M, Ma J, Chu Z, et al. Musashi1 inhibit the release of Newcastle disease viruses through preventing apoptosis of DF-1 cells. Poult Sci. 2021;100(7):101105. doi: 10.1016/j.psj.2021.101105
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhan W, Cao T, et al. CacyBP/SIP inhibits Doxourbicin-induced apoptosis of glioma cells due to activation of ERK1/2. IUBMB Life. 2016;68(3):211–9. doi: 10.1002/iub.1477
   PubMed Web of Science ®Google Scholar
• Fu C, Wan Y, Shi H, et al. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis. J Cancer Res Clin Oncol. 2016;142(4):741–8. doi: 10.1007/s00432-015-2077-0
   PubMed Web of Science ®Google Scholar
• Chu Z, Wang C, Tang Q, et al. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP. Front Cell Infect Microbiol. 2018;8:304. doi: 10.3389/fcimb.2018.00304
   PubMed Web of Science ®Google Scholar
• Tong L, Chu Z, Gao X, et al. Newcastle disease virus V protein interacts with hnRNP H1 to promote viral replication. Vet Microbiol. 2021;260:109093. doi: 10.1016/j.vetmic.2021.109093
   PubMed Web of Science ®Google Scholar
• Karsunke J, Heiden S, Murr M, et al. W protein expression by Newcastle disease virus. Virus Res. 2019;263:207–216. doi: 10.1016/j.virusres.2019.02.003
   PubMed Web of Science ®Google Scholar
• Park, MS, Shaw, ML, Munoz-Jordan J, et al. Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J Virol. 2003;77(2):1501–1511. doi: 10.1128/JVI.77.2.1501-1511.2003
   PubMed Web of Science ®Google Scholar
• Fu X, Liang C, Li F, et al. The rules and functions of nucleocytoplasmic shuttling proteins. Int J Mol Sci. 2018;19(5):1445. doi: 10.3390/ijms19051445
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Yamada K, Yoneda Y. Importin α: a key molecule in nuclear transport and non-transport functions. J Biochem. 2016;160(2):69–75. doi: 10.1093/jb/mvw036
   PubMed Web of Science ®Google Scholar
• Yang Y, Xue J, Teng Q, et al. Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria. J Virol. 2021;95(7):e02087–20. doi: 10.1128/JVI.02087-20
   PubMed Web of Science ®Google Scholar
• Kim YH, Han ME, Oh SO. The molecular mechanism for nuclear transport and its application. Anat Cell Biol. 2017;50(2):77–85. doi: 10.5115/acb.2017.50.2.77
   PubMed Web of Science ®Google Scholar
• Battisti AJ, Meng G, Winkler DC, et al. Structure and assembly of a paramyxovirus matrix protein. P Natl Acad Sci USA. 2012;109(35):13996–4000. doi: 10.1073/pnas.1210275109
   PubMed Web of Science ®Google Scholar
• Duan Z, Deng S, Ji X, et al. Nuclear localization of Newcastle disease virus matrix protein promotes virus replication by affecting viral RNA synthesis and transcription and inhibiting host cell transcription. Vet Res. 2019;50(1):22. doi: 10.1186/s13567-019-0640-4
   PubMedGoogle Scholar
• Duan Z, Song Q, Wang Y, et al. Characterization of signal sequences determining the nuclear export of Newcastle disease virus matrix protein. Arch Virol. 2013;158(12):2589–95. doi: 10.1007/s00705-013-1769-5
   PubMed Web of Science ®Google Scholar
• Duan Z, Xu H, Ji X, et al. Importin alpha5 negatively regulates importin beta1-mediated nuclear import of Newcastle disease virus matrix protein and viral replication and pathogenicity in chicken fibroblasts. Virulence. 2018;9(1):783–803. doi: 10.1080/21505594.2018.1449507
   PubMed Web of Science ®Google Scholar
• Duan Z, Chen J, Xu H, et al. The nucleolar phosphoprotein B23 targets Newcastle disease virus matrix protein to the nucleoli and facilitates viral replication. Virology. 2014;452-453:212–22. doi: 10.1016/j.virol.2014.01.011
   PubMed Web of Science ®Google Scholar
• Duan Z, Han Y, Zhou L, et al. Chicken bromodomain-containing protein 2 interacts with the Newcastle disease virus matrix protein and promotes viral replication. Vet Res. 2020;51(1):120. doi: 10.1186/s13567-020-00846-1
   PubMed Web of Science ®Google Scholar
• Zhou L, Han YF, Yuan C, et al. Screening and bioinformatics analysis of cellular proteins interacting with chicken bromodomain-containing protein 2 in DF-1 cells. Br Poultry Sci. 2021;62(6):810–819. doi: 10.1080/00071668.2021.1943311
   PubMed Web of Science ®Google Scholar
• Pantua HD, McGinnes LW, Peeples ME, et al. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol. 2006;80(22):11062–73. doi: 10.1128/JVI.00726-06
   PubMed Web of Science ®Google Scholar
• Duan Z, Hu Z, Zhu J, et al. Mutations in the FPIV motif of Newcastle disease virus matrix protein attenuate virus replication and reduce virus budding. Arch Virol. 2014;159(7):1813–9. doi: 10.1007/s00705-014-1998-2
   PubMed Web of Science ®Google Scholar
• Peng T, Qiu X, Tan L, et al. Ubiquitination on lysine 247 of Newcastle disease virus matrix protein enhances viral replication and virulence by Driving Nuclear-Cytoplasmic Trafficking. J Virol. 2022;96(2):e0162921. doi: 10.1128/JVI.01629-21
   PubMed Web of Science ®Google Scholar
• Duan Z, Zhang Q, Liu M, et al. Multifunctionality of matrix protein in the replication and pathogenesis of Newcastle disease virus: A review. Int j biol macromol. 2023;249:126089. doi: 10.1016/j.ijbiomac.2023.126089
   PubMed Web of Science ®Google Scholar
• Cibulka J, Fraiberk M, Forstova J. Nuclear actin and lamins in viral infections. Viruses. 2012;4(3):325–47. doi: 10.3390/v4030325
   PubMed Web of Science ®Google Scholar
• Giuffre RM, Tovell DR, Kay CM, et al. Evidence for an interaction between the membrane protein of a paramyxovirus and actin. J Virol. 1982;42(3):963–8. doi: 10.1128/jvi.42.3.963-968.1982
   PubMed Web of Science ®Google Scholar
• Laliberte JP, McGinnes LW, Peeples ME, et al. Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J Virol. 2006;80(21):10652–62. doi: 10.1128/JVI.01183-06
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Cao H, et al. Engagement of new castle disease virus (NDV) matrix (M) protein with charged multivesicular body protein (CHMP) 4 facilitates viral replication. Virus Res. 2013;171(1):80–8. doi: 10.1016/j.virusres.2012.10.033
   PubMed Web of Science ®Google Scholar
• Bauer A, Neumann S, Karger A, et al. ANP32B is a nuclear target of henipavirus M proteins. PLoS One. 2014;9(5):e97233. doi: 10.1371/journal.pone.0097233
   PubMed Web of Science ®Google Scholar
• Gunther M, Bauer A, Muller M, et al. Interaction of host cellular factor ANP32B with matrix proteins of different paramyxoviruses. J Gen Virol. 2020;101(1):44–58. doi: 10.1099/jgv.0.001362
   PubMed Web of Science ®Google Scholar
• Shah M, Bharadwaj MSK, Gupta A, et al. Chicken viperin inhibits Newcastle disease virus infection in vitro: A possible interaction with the viral matrix protein. Cytokine. 2019;120:28–40. doi: 10.1016/j.cyto.2019.04.007
   PubMed Web of Science ®Google Scholar
• Ren S, Ur Rehman Z, Gao B, et al. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells. PLOS Pathog. 2020;16(6):e1008514. doi: 10.1371/journal.ppat.1008514
   PubMed Web of Science ®Google Scholar
• Wang C, Wang T, Hu R, et al. Cyclooxygenase-2 Facilitates Newcastle Disease Virus Proliferation and is as a Target for Canthin-6-One Antiviral Activity. Front Microbiol. 2020;11:987. doi: 10.3389/fmicb.2020.00987
   PubMed Web of Science ®Google Scholar
• Winn J, Carter M, Avery L, et al. Hox and a newly identified E2F co-repress cell death in Caenorhabditis elegans. Genetics. 2011;188(4):897–905. doi: 10.1534/genetics.111.128421
   PubMed Web of Science ®Google Scholar
• Molouki A, Hsu YT, Jahanshiri F, et al. The matrix (M) protein of Newcastle disease virus binds to human Bax through its BH3 domain. Virol J. 2011;8(3):385. doi: 10.1186/1743-422X-8-385
   PubMedGoogle Scholar
• Rangaswamy US, Wang W, Cheng X, et al. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells in Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase. J Virol. 2017;91(16):e00770–17. doi: 10.1128/JVI.00770-17
   PubMed Web of Science ®Google Scholar
• Baker KA, Dutch RE, Lamb RA, et al. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell. 1999;3(3):309–19. doi: 10.1016/S1097-2765(00)80458-X
   PubMed Web of Science ®Google Scholar
• Bu Y, Teng Q, Feng D, et al. Adaptor complex-mediated trafficking of Newcastle disease virus fusion protein is regulated by the YLMY motif of its cytoplasmic tail. Virulence. 2022;13(1):1849–1867. doi: 10.1080/21505594.2022.2136433
   PubMed Web of Science ®Google Scholar
• Kim SH, Subbiah M, Samuel AS, et al. Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses. J Virol. 2011;85(17):8582–96. doi: 10.1128/JVI.00652-11
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Matsumae H, Katoh M, et al. A comprehensive map of the influenza a virus replication cycle. BMC Syst Biol. 2013;7(1):97. doi: 10.1186/1752-0509-7-97
   PubMedGoogle Scholar
• Yan C, Liu H, Jia Y, et al. Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus. Poult Sci. 2020;99(7):3374–3384. doi: 10.1016/j.psj.2020.04.014
   PubMed Web of Science ®Google Scholar
• Owen DJ, Collins BM, Evans PR. Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Bi. 2004;20(1):153–91. doi: 10.1146/annurev.cellbio.20.010403.104543
   PubMedGoogle Scholar
• Traub LM. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Bio. 2009;10(9):583–96. doi: 10.1038/nrm2751
   PubMed Web of Science ®Google Scholar
• Berhanu A, Ideris A, Omar AR, et al. Molecular characterization of partial fusion gene and C-terminus extension length of haemagglutinin-neuraminidase gene of recently isolated Newcastle disease virus isolates in Malaysia. Virol J. 2010;7(1):183. doi: 10.1186/1743-422X-7-183
   PubMedGoogle Scholar
• Jin Z, Wei Q, Bi Y, et al. Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus. Virol J. 2021;18(1):8. doi: 10.1186/s12985-020-01483-y
   PubMed Web of Science ®Google Scholar
• Yuan P, Swanson KA, Leser GP, et al. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. P Natl Acad Sci USA. 2011;108(36):14920–5. doi: 10.1073/pnas.1111691108
   PubMed Web of Science ®Google Scholar
• Sun J, Han Z, Shao Y, et al. Comparative proteome analysis of tracheal tissues in response to infectious bronchitis coronavirus, Newcastle disease virus, and avian influenza virus H9 subtype virus infection. Proteomics. 2014;14(11):1403–23. doi: 10.1002/pmic.201300404
   PubMed Web of Science ®Google Scholar
• Sun J, Han Z, Qi T, et al. Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein. J Biol Chem. 2017;292(49):20141–20161. doi: 10.1074/jbc.M116.772897
   PubMed Web of Science ®Google Scholar
• Ramos I, Stamatakis K, Oeste CL, et al. Vimentin as a multifaceted player and potential therapeutic target in viral infections. Int J Mol Sci. 2020;21(13):4675. doi: 10.3390/ijms21134675
   PubMed Web of Science ®Google Scholar
• Lu X, Liu K, Chen Y, et al. Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein. Vet Res. 2023;54(1):92. doi: 10.1186/s13567-023-01230-5
   PubMed Web of Science ®Google Scholar
• Dai J, Dan W, Schneider U, et al. β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities. Eur J Med Chem. 2018;157:622–656. doi: 10.1016/j.ejmech.2018.08.027
   PubMed Web of Science ®Google Scholar
• Chen D, Su A, Fu Y, et al. Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress. Antivir Res. 2015;123:27–38. doi: 10.1016/j.antiviral.2015.09.003
   PubMed Web of Science ®Google Scholar
• Chen D, Tian X, Zou X, et al. Harmine, a small molecule derived from natural sources, inhibits enterovirus 71 replication by targeting NF-κB pathway. Int Immunopharmacol. 2018;60:111–120. doi: 10.1016/j.intimp.2018.04.050
   PubMed Web of Science ®Google Scholar
• Wang C, Wang T, Dai J, et al. 1-Formyl-beta-carboline Derivatives Block Newcastle Disease Virus Proliferation through Suppressing Viral Adsorption and Entry Processes. Biomolecules. 2021;11(11):1687. doi: 10.3390/biom11111687
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Q, Xu D, et al. Antitumor effect of the Newcastle disease viral hemagglutinin-neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells. Anti-Cancer Drug. 2018;29(3):197–207. doi: 10.1097/CAD.0000000000000575
   PubMed Web of Science ®Google Scholar
• Baradaran A, Yusoff K, Shafee N, et al. Newcastle disease virus hemagglutinin neuraminidase as a potential Cancer targeting agent. J Cancer. 2016;7(4):462–6. doi: 10.7150/jca.13566
   PubMed Web of Science ®Google Scholar
• Vanlandschoot P, Stortelers C, Beirnaert E, et al. Nanobodies®: new ammunition to battle viruses. Antivir Res. 2011;92(3):389–407. doi: 10.1016/j.antiviral.2011.09.002
   PubMed Web of Science ®Google Scholar
• Gao X, Hu X, Tong L, et al. Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus. BMC Vet Res. 2016;12(1):39. doi: 10.1186/s12917-016-0664-1
   PubMedGoogle Scholar
• Sourimant J, Rameix-Welti MA, Gaillard AL, et al. Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein. J Virol. 2015;89(8):4421–33. doi: 10.1128/JVI.03619-14
   PubMed Web of Science ®Google Scholar
• Wang P, Kong F, Wei J, et al. Alkaloids from the mangrove-derived actinomycete jishengella endophytica 161111. Mar Drug. 2014;12(1):477–90. doi: 10.3390/md12010477
   PubMed Web of Science ®Google Scholar
• Wang YH, Tang JG, Wang RR, et al. Flazinamide, a novel beta-carboline compound with anti-HIV actions. Biochem Biophys Res Commun. 2007;355(4):1091–1095. doi: 10.1016/j.bbrc.2007.02.081
   PubMed Web of Science ®Google Scholar
• Wang C, Wang T, Hu R, et al. 9-butyl-harmol exerts antiviral activity against Newcastle disease virus through targeting GSK-3β and HSP90β. J Virol. 2023;97(3):e0198422. doi: 10.1128/jvi.01984-22
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu W, Xu H, et al. MicroRNA Expression Profiling in Newcastle Disease Virus-Infected DF-1 Cells by Deep Sequencing. Front Microbiol. 2019;10:1659. doi: 10.3389/fmicb.2019.01659
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu S, Hu J, et al. Gga-miR-1603 and gga-miR-1794 directly target viral L gene and function as a broad-spectrum antiviral factor against NDV replication. Virulence. 2021;12(1):45–56. doi: 10.1080/21505594.2020.1864136
   PubMed Web of Science ®Google Scholar
• Liu YC, Grusovin J, Adams TE, et al. Electrostatic Interactions between Hendra Virus Matrix Proteins are Required for Efficient Virus-Like-Particle Assembly. J Virol. 2018;92(13):e00143–18. doi: 10.1128/JVI.00143-18
   PubMed Web of Science ®Google Scholar
• Lin LT, Richardson CD. The host cell receptors for measles virus and their interaction with the viral hemagglutinin (H) protein. Viruses. 2016;8(9):250. doi: 10.3390/v8090250
   PubMed Web of Science ®Google Scholar
• Irie T, Kiyotani K, Igarashi T, et al. Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol. 2012;86(13):7136–45. doi: 10.1128/JVI.06705-11
   PubMed Web of Science ®Google Scholar
• Komatsu T, Tanaka Y, Kitagawa Y, et al. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly. J Virol. 2018;92(19):e00842–18. doi: 10.1128/JVI.00842-18
   PubMed Web of Science ®Google Scholar
• Li M, Schmitt PT, Li Z, et al. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol. 2009;83(14):7261–72. doi: 10.1128/JVI.00421-09
   PubMed Web of Science ®Google Scholar
• Pei Z, Bai Y, Schmitt AP. PIV5 M protein interaction with host protein angiomotin-like 1. Virology. 2010;397(1):155–66. doi: 10.1016/j.virol.2009.11.002
   PubMed Web of Science ®Google Scholar
• Jiang L, Chen H, Li C. Advances in deciphering the interactions between viral proteins of influenza a virus and host cellular proteins. Cell Insight. 2023;2(2):100079. doi: 10.1016/j.cellin.2023.100079
   PubMedGoogle Scholar
• Hu Y, Okyere SK, Xu R, et al. Assessment of antiviral activity and mechanism of rhein on Newcastle disease virus (La Sota strain IV) in vitro. Nat Prod Res. 2022;36(5):1400–1404. doi: 10.1080/14786419.2021.1878515
   PubMed Web of Science ®Google Scholar